Search - tctmd.com

Displaying 21 - 40 of 87

Sort: Relevancy | Date

Presentation TCT 2020

TCT 281: Clinical Outcomes of Optical Coherence Tomography Detected High Risk Versus Low Risk Coronary Atherosclerotic Lesions in Medically Treated Fractional Flow Reserve Negative Lesions in Diabetes Mellitus Patients. The COMBINE Trial.

Presenter: Elvin Kedhi

October 14, 2020

Presentation TVT 2020

Transcatheter Aortic Valve Replacement using an Evolut PRO Bioprosthesis in Low Risk Patients with Aortic Stenosis

Presenter: Bruce Rutkin

June 20, 2020

Presentation Live Valves 2019

All AS Patients ( incl. Low-Risk) should be treated with TAVI

Presenter: Christian W. Hamm

December 10, 2019

Presentation CACI 2019

TAVI in Low Risk Patients

Presenter: Fayaz Shawl

November 29, 2019

Presentation TCT Abstracts Posters 2019

Transcatheter Aortic Valve Replacement in Low-risk Patients A Meta-analysis of Randomized Controlled Trials

Presenter: Ahmad Al-Abdouh

October 06, 2019

Presentation TCT Abstracts Posters 2019

Distribution of coronary artery disease in patients with low-risk transcatheter aortic valve replacement: A computed tomography coronary angiography study (from the LRT trial)

Presenter: Yuichi Ozaki

September 29, 2019

Presentation TCT 2019

TAVR in Low-Risk Patients: Strengths and Limitations of the Low-Risk Trials

Presenter: Robert Bonow

September 28, 2019

Presentation TCT 2019

Magnitude of Antihypertensive Effect After Renal Denervation: Is It Sufficient for High-Risk as Well as Low-Risk Patients?

Presenter: Justin Davies

September 28, 2019

Presentation TCT 2019

Remaining Data Gaps After the Low-Risk TAVR RCTs

Presenter: Michael Borger

September 26, 2019

Presentation TCT 2019

Deep-Dive: NEW Insights From the Evolut Low-Risk Trial

Presenter: Michael Reardon

September 26, 2019

Presentation TCT 2019

TCT 20: Aortic Root Anatomy in Low Risk Patients After Transcatheter Aortic Valve Replacement with a Balloon-Expandable Valve: Impact on Coronary Access and Repeat Aortic Valve Interventions

Presenter: Toby Rogers

September 25, 2019

Presentation TCT 2019

The Clinical Evidence: Extreme- to Low-Risk Patients

Presenter: Michael Reardon

September 25, 2019

Presentation TVT 2019

Hemodynamic Outcomes and Predictors of Prosthesis-Patient Mismatch After Transcatheter or Surgical Aortic Valve Replacement in Low-Risk Patients: Results from the Evolut Low-Risk Trial

Presenter: Mubashir Mumtaz

June 14, 2019

Presentation TVT 2019

Echocardiographic Results of Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients: The PARTNER 3 Trial

Presenter: Philippe Pibarot

June 14, 2019

Presentation TVT 2019

Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients: A Meta-Analysis of Randomized Controlled Trials

Presenter: Dhaval Kolte

June 13, 2019

Presentation TVT 2019

Meta-Analysis of 1-Year Outcomes of Transcatheter vs. Surgical Aortic Valve Replacement in Low-Risk Patients With Severe Aortic Stenosis

Presenter: Aaqib H Malik

June 13, 2019

Presentation SIF 2019

My Prediction on TAVR in Low Risk Patients

Presenter: Kendra J. Grubb

March 30, 2019

Presentation ACC 2019

PARTNER 3: Transcatheter or Surgical Aortic Valve Replacement in Low Risk Patients with Aortic Stenosis

Presenter: Martin B. Leon

March 17, 2019

Presentation CRT 2019

Transcatheter aortic valve replacement in low-risk patients with symptomatic severe aortic stenosis

Presenter: Ron Waksman

March 05, 2019

Presentation

Durability of Transcatheter and Surgical Bioprosthetic Aortic Valves in Patients at Low Risk

February 06, 2019

Advertisement

TCT 281: Clinical Outcomes of Optical Coherence Tomography Detected High Risk Versus Low Risk Coronary Atherosclerotic Lesions in Medically Treated Fractional Flow Reserve Negative Lesions in Diabetes Mellitus Patients. The COMBINE Trial.

Transcatheter Aortic Valve Replacement using an Evolut PRO Bioprosthesis in Low Risk Patients with Aortic Stenosis

All AS Patients ( incl. Low-Risk) should be treated with TAVI

TAVI in Low Risk Patients

Transcatheter Aortic Valve Replacement in Low-risk Patients A Meta-analysis of Randomized Controlled Trials

Distribution of coronary artery disease in patients with low-risk transcatheter aortic valve replacement: A computed tomography coronary angiography study (from the LRT trial)

TAVR in Low-Risk Patients: Strengths and Limitations of the Low-Risk Trials

Magnitude of Antihypertensive Effect After Renal Denervation: Is It Sufficient for High-Risk as Well as Low-Risk Patients?

Remaining Data Gaps After the Low-Risk TAVR RCTs

Deep-Dive: NEW Insights From the Evolut Low-Risk Trial

TCT 20: Aortic Root Anatomy in Low Risk Patients After Transcatheter Aortic Valve Replacement with a Balloon-Expandable Valve: Impact on Coronary Access and Repeat Aortic Valve Interventions

The Clinical Evidence: Extreme- to Low-Risk Patients

Hemodynamic Outcomes and Predictors of Prosthesis-Patient Mismatch After Transcatheter or Surgical Aortic Valve Replacement in Low-Risk Patients: Results from the Evolut Low-Risk Trial

Echocardiographic Results of Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients: The PARTNER 3 Trial

Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients: A Meta-Analysis of Randomized Controlled Trials

Meta-Analysis of 1-Year Outcomes of Transcatheter vs. Surgical Aortic Valve Replacement in Low-Risk Patients With Severe Aortic Stenosis

My Prediction on TAVR in Low Risk Patients

PARTNER 3: Transcatheter or Surgical Aortic Valve Replacement in Low Risk Patients with Aortic Stenosis

Transcatheter aortic valve replacement in low-risk patients with symptomatic severe aortic stenosis

Durability of Transcatheter and Surgical Bioprosthetic Aortic Valves in Patients at Low Risk

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content